Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 USD | -0.01% | -1.93% | +17.05% |
02/05 | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.05% | 323B | |
+28.73% | 662B | |
+22.48% | 546B | |
-4.76% | 359B | |
+4.66% | 289B | |
+13.68% | 234B | |
+4.04% | 198B | |
-10.43% | 194B | |
+5.19% | 167B | |
-2.28% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Completes Acceleron Pharma Acquisition